{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-22-000366","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2022-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.873528+00:00","generated_at":"2026-06-27T01:27:58.537375+00:00","sec_items":["4.01","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Anavex Life Sciences changes auditor from BDO to Grant Thornton LLP; no disagreements reported","bullets":["Dismissed BDO as independent auditor on March 1, 2022; no adverse opinions or disagreements in prior two fiscal years.","Engaged Grant Thornton as new independent auditor for FY ending Sep 30, 2022 after competitive process by Audit Committee.","Entered Amendment No.2 to employment agreement with Principal Financial Officer Sandra Boenisch, effective March 1, 2022, increasing annual base salary to $240,000 CAD.","Press release issued March 4, 2022 announcing the auditor change."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-22-000366","json":"https://secwatch.observer/filing/0001731122-22-000366.json","markdown":"https://secwatch.observer/filing/0001731122-22-000366.md","text":"https://secwatch.observer/filing/0001731122-22-000366.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222000366/0001731122-22-000366-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222000366/e3562_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T01:27:58.537375+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}